Scientists have taken a significant step toward developing an effective vaccine against shigellosis, the infection caused by Shigella bacteria. In…
Read More
Groundbreaking Discovery at University of Gothenburg Identifies Dual-Function Protein as Key Target for Genital Herpes Vaccine Development
Researchers at the University of Gothenburg in Sweden have announced a significant breakthrough in the quest for a vaccine against…
Read More
CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and Uganda
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…
Read More
Anixa Biosciences Secures Key Patent for Breast Cancer Vaccine Technology in South Korea, Expanding Global Intellectual Property Portfolio
Anixa Biosciences has achieved a significant milestone in its quest to develop a preventive vaccine for breast cancer, securing a…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Vaccine Policy and Ongoing Public Health Challenges
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound concern…
Read More
A New Vaccine Adjuvant Could Revolutionize Polio Eradication by Inducing Robust Mucosal Immunity
Researchers at the Massachusetts Institute of Technology (MIT) have unveiled a groundbreaking vaccine adjuvant designed to bolster the effectiveness of…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna and Oxford
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford to Combat Bundibugyo Outbreak
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…
Read MoreYOU MAY HAVE MISSED
